ArticleFrontiers in medicine2026
Preliminary clinical and structural outcomes of a standardized ultrasound-guided diagnostic and interventional protocol for refractory adhesive capsulitis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adhesive capsulitis is common and often prolonged condition characterized by pain and progressive restriction of glenohumeral motion, with a substantial proportion of patients experiencing persistent symptoms and functional limitations. Despite the wide range of available treatments, clinical outcomes remain variable, reflecting heterogeneity in both diagnostic approaches and therapeutic strategies. Objective: To describe the short-term clinical and sonographic evolution following a standardized ultrasound guided diagnostic and interventional pathway combining suprascapular nerve block and glenohumeral hydrodilatation in patients with refractory adhesive capsulitis. Methods: This study is a retrospective analysis of a prospectively maintained clinical database of patients managed within a standardized care pathway in a tertiary musculoskeletal interventional unit between December 2023 and April 2024. Patients with clinically and sonographically confirmed refractory adhesive capsulitis who underwent the combined protocol were included. Pain intensity, shoulder range of motion, and ultrasound-measured capsular thickness were recorded at baseline and at 3-months. Routine clinical follow-up was available for up to 12 months. Results: 16 patients with confirmed adhesive capsulitis underwent the combined intervention. At 3 months, pain scores and range-of-motion measurements had improved compared with baseline, and ultrasound assessment demonstrated a reduction in inferior glenohumeral capsular thickness. No major procedural complications were documented. During routine clinical follow-up to 12 months, no recurrence was documented; one patient had persistent residual symptoms attributed to concomitant calcific tendinopathy. Conclusion: In this small uncontrolled cohort, a standardized ultrasound-guided pathway was followed by clinically meaningful improvements in pain and shoulder mobility and by a reduction in capsular thickness at 3 months. The parallel clinical and sonographic changes observed in this refractory population support further investigation of this integrated pathway. Although causality and the independent contribution of individual procedural components cannot be established, these preliminary findings provide a rationale for prospective controlled evaluation with blinded outcome assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.